Continuous Glucose Monitor

Dexcom G7 CGM System

• 87/100 science score
• $89 price

Overview

Dexcom G7 excels in effectiveness with industry-leading 8.2% MARD from pivotal study (Garg 2022), enabling fingerstick replacement per FDA. Safety solid in trials (no SAEs) but tempered by post-market MAUDE reports of sensor failures/skin issues common to wearables. Quality high via FDA clearance and spec transparency, though lacks supplement certs irrelevant to devices. Overall premium med device for glucose monitoring.

Key strengths

• Industry-best 8.2% MARD in pivotal study (Garg 2022), accurate across ranges/sites.
• FDA cleared for ages 2+, integrates with AID systems.
• 10-15 day wear, 30-min warm-up.

Our analysis

Dexcom G7 is a top-tier CGM with proven 8.2% MARD accuracy from pivotal study and FDA clearance, ideal for diabetes management. Mild trial safety offset by post-market device issues. Excellent for real-time monitoring despite cost.

Frequently asked questions

Is Dexcom G7 CGM System worth buying?

Dexcom G7 CGM System has a Verify Influencers trust score of 87/100 based on ingredient quality, clinical evidence, and third-party testing.

What is the trust score for Dexcom G7 CGM System?

Dexcom G7 CGM System scored 87 out of 100 in our science-backed analysis, which evaluates ingredient dosages against clinical literature and manufacturing transparency.

Browse all scored products · How products are scored